检索结果 - Hiroyuki Ida
- Showing 1 - 6 results of 6
-
1
-
2
-
3
-
4
Once- versus twice-daily dosing of eliglustat in adults with Gaucher disease type 1: The Phase 3, randomized, double-blind EDGE trial 由 Joel Charrow, Cristina Fraga, Xuefan Gu, Hiroyuki Ida, Nicola Longo, Elena Lukina, Alexandre Nonino, Sebastiaan J.M. Gaemers, Marie-Hélène Jouvin, Jing Li, Yaoshi Wu, Yong Xue, Michel Peterschmitt
出版 2018Artigo -
5
N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease 由 Hou Lin, Yuko Sugimoto, Yuki Ohsaki, Haruaki Ninomiya, Akira Oka, Miyako Taniguchi, Hiroyuki Ida, Yoshikatsu Eto, Seiichiro Ogawa, Yumi Matsuzaki, Miwa Sawa, Takehiko Inoue, Katsumi Higaki, Eiji Nanba, Kousaku Ohno, Yoshiyuki Suzuki
出版 2004Artigo -
6
Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial 由 Raphael Schiffmann, Timothy M. Cox, Jean-François Dedieu, Sebastiaan J.M. Gaemers, Julia B. Hennermann, Hiroyuki Ida, Eugen Mengel, Pascal Minini, Pramod K. Mistry, Petra B. Musholt, David Scott, Jyoti Sharma, Michel Peterschmitt
出版 2022Artigo
相关主题
Medicine
Disease
Internal medicine
Biology
Gene
Genetics
Pathology
Adverse effect
Cell biology
Embryonic stem cell
Endocrinology
Enzyme replacement therapy
Gastroenterology
Induced pluripotent stem cell
Myocyte
Pediatrics
Randomized controlled trial
Stem cell
Tolerability
Allergy
Alternative medicine
Anatomy
Atopic dermatitis
Biochemistry
Bioinformatics
Cardiomyopathy
Cell culture
Chemical chaperone
Clinical endpoint
Cmax